Company Overview

Development Stage

About the Company

Xiangrui Biological (stock code: 873821), founded in 2000, is a member of the Simcere Investment Group, located by Yanqi Lake in Beijing, within Huairou Science City. With the goal of 'developing innovative vaccines for human health', the company focuses on anti-infection, infectious diseases, and vaccines, integrating R&D, production, and sales of biological products for prevention, biologics, and in vitro diagnostic reagents. As a national high-tech enterprise, Beijing's 'Specialized, Refined, Distinctive and Innovative' small giant enterprise, and the tuberculosis medical transformation innovation base of the Chinese Anti-Tuberculosis Association, the company's vision is 'making health simpler'. With over 20 years of deep involvement in the anti-infection and infectious disease fields, it specializes in innovative human vaccines and tuberculosis screening diagnostics, and is one of the 43 companies in China holding a vaccine production license, leading the domestic tuberculosis field.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Simcere Xiangrui Financing History (1 rounds)

Manage
新三板
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 新三板
  • Deal: 全国股转系统

Simcere Xiangrui How Fast Is Hiring Growing? (116 open positions)

Manage
Note: How fast is hiring at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd. growing? Simcere Xiangrui2025: 243 openings (up 63%), 2024: 149 openings (down 7%), 2023: 160 openings (up 627%), 2022: 22 openings (down 67%), 2021: 66 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Simcere Xiangrui Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 86%
  • 2023: Up 133%
  • 2022: Up 125%
Simcere Xiangrui Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd. growing? Simcere XiangruiMaster's recruitment over the years: 2025: 3 openings (flat), 2024: 3 openings (down 86%), 2023: 21 openings (up 133%), 2022: 9 openings (up 125%), 2021: 4 openings.

Simcere Xiangrui Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Simcere Xiangrui Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd. growing? Simcere XiangruiDoctorate recruitment over the years: 2026: 8 openings (up 267%), 2024: 1 openings (down 86%), 2023: 2 openings (up 133%), 2022: 1 openings (up 125%).

Simcere Xiangrui R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd.? Based on an analysis of Simcere Xiangrui's job postings over the past year, "医疗卫生/美容保健类" demand: 6.8%, "生物/制药/化工/环保类": 6%, "其他(研发和技术类)": 4.3%, "计算机/网络/技术类": 3.8%, "机械/仪器仪表类": 1.3%. For reference only.

Simcere Xiangrui — What Are the Salaries Like? (234 records)

Manage
salary range: 6K - 50K, 62.4% of roles pay ¥10-20K
Note: salary statistics are based on 234 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd.?Simcere Xiangrui62.4% of positions earn 10-20K, Fresh graduate salary: ¥11.4K。销售类 average salary ¥16.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Simcere Xiangrui

(More)
Are salaries high at Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd.? We provide: 省区经理,学术专员,招商,医药代表,产品经理,销售,分装,大区经理,财务,生产技术,研发总监,项目经理,qa,qc,实习生,推广,注册专员,灌装,研发工程师,设备维修. Click to view detailed salary analysis by job.

Simcere Xiangrui honors, qualifications & industry associations

Simcere Xiangrui Related Industry Tags

Job Category

  • 销售类
    65% of total 65%
  • 经营管理类
    37.6% of total 37.6%
  • 工厂生产类
    9% of total 9%
  • 医疗卫生/美容保健类
    6.8% of total 6.8%

Education

  • 本科
    57.3% of total 57.3%
  • 大专
    33.3% of total 33.3%
  • 硕士
    5.1% of total 5.1%
  • 博士
    3.4% of total 3.4%

Experience

  • 1-3年
    35.5% of total 35.5%
  • 不限
    21.4% of total 21.4%
  • 3-5年
    19.7% of total 19.7%
  • 5-10年
    19.2% of total 19.2%
View Detailed Analysis

What does Beijing Simcere Xiangrui Biological Products Joint-stock Co., Ltd. require? Who is Simcere Xiangrui hiring? Simcere Xiangrui recruitment: 销售类占比最多占65%,其次是经营管理类占37.6%. What education can get in at Simcere Xiangrui? 本科占比最多占57.3%,其次是大专占33.3%. High education required at Simcere Xiangrui? 硕士占5.1%,博士占3.4%. Work experience required at Simcere Xiangrui? 1-3年占比最多占35.5%,其次是不限占21.4%. Where are the job locations at Simcere Xiangrui? 北京占比最多占29.5%,其次是南京占10.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 38,218万(元)
Legal Representative: 田家伦
Date Established:
Credit Code: 911101161029817358
Registered Address: 北京市怀柔区雁栖经济开发区雁栖北三街17号

Partners & Suppliers

2020年8月,科兴中维委托先声祥瑞进行新冠疫苗的分装和包装生产 Source
合作客户 疫苗分装/代工

People who follow Simcere Xiangrui also follow

Simcere Xiangrui Competitors (Similar Companies)

“Seek and strive, protect and heal all beings”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“To develop high-quality biologics that are accessible and affordable f”
“Global integrated biopharmaceutical enterprise”
医药 医药服务 CRO 临床研究
“Continuously innovating to bring patients medicines that significantly”
“Committed to continuous innovation in biotechnology, providing product”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A leader in China's pharmaceutical and healthcare market”
生物科技/生物工程 科学服务 基因合成 CRO
“Research, development, and production of anti-tumor and surgical medic”
“One of China's Top 20 Listed Pharmaceutical Companies”
医药 工程技术 制药工程 医药工业
“Helping patients access more effective medicines sooner”
“Caring for life, safeguarding health”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates